CV Lattes
GoogleMyCitations
ResearcherID
ORCID
Universidade Estadual Paulista (UNESP). Campus de Araçatuba. Faculdade de Odontologia (FOA) (Institutional affiliation for the last research proposal) Birthplace: Brazil
graduation at Biomedicina from Universidade Paulista (2019). Has experience in Collective Health, acting on the following subjects: osteoblastic differentiation, mesenchymal stromal cells and telmisartan. (Source: Lattes Curriculum)
Suppression of the renin-angiotensin system (RAS) for decades is desired for the treatment of systemic arterial hypertension, due to its effects of vasoconstriction and increased blood pressure. Currently, various drugs are capable of performing such study, for example, telmisartan which is an angiotensin II (AT 1) type 1 receptor antagonist. The RAS also operates locally and its componen…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 1 |
| Citations | 0 |
| Cit./Article | 0.0 |
| Data from Web of Science | |
BALERA BRITO, VICTOR GUSTAVO; PATROCINIO, MARIANA SOUSA; LINJARDI SOUSA, MARIA CAROLINA; ALVES BARRETO, AYNA EMANUELLI; TFAILE FRASNELLI, SABRINA CRUZ; LARA, VANESSA SOARES; SANTOS, CARLOS FERREIRA; PENHA OLIVEIRA, SANDRA HELENA. Mast cells contribute to alveolar bone loss in Spontaneously Hypertensive Rats with periodontal disease regulating cytokines production. PLoS One, v. 16, n. 3, MAR 4 2021. Web of Science Citations: 0. (18/23676-3, 17/05873-3, 17/07095-8, 17/02271-2, 15/03965-2)
BRITO, VICTOR GUSTAVO BALERA; PATROCINIO, MARIANA SOUSA; DE SOUSA, MARIA CAROLINA LINJARDI; BARRETO, AYNA EMANUELLI ALVES; FRASNELLI, SABRINA CRUZ TFAILE; LARA, VANESSA SOARES; SANTOS, CARLOS FERREIRA; OLIVEIRA, SANDRA HELENA PENHA. Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease. FRONTIERS IN PHARMACOLOGY, v. 11, NOV 11 2020. Web of Science Citations: 0. (17/02271-2, 18/23676-3, 17/05873-3, 17/07095-8, 15/03965-2)